Ingrowth Biotech becomes first Taiwan-based maker of 3D-printed implantable medical devices

Taipei, Sunday, January 19, 2020 20:36 (GMT+8),

15°C

中文繁體 | 簡體

We have recently changed our search engine. Check the Advanced options to learn the new search rules.

Asian Edge: On the Frontline of the ICT World

IT + CE

Ingrowth Biotech becomes first Taiwan-based maker of 3D-printed implantable medical devices

Rebecca Kuo, Tainan; Adam Hwang, DIGITIMES

Tuesday 19 June 2018

Ingrowth Biotech, a subsidiary of metal-alloy chassis maker Catcher Technology, has passed ISO 13485, requirements for quality management for medical devices, and GMP (good manufacturing practice) certification for the first category of medical devices...

The article you are trying to open requires News database subscription. Please sign in if you wish to continue.

Sponsored links

Mini/micro LED: Challenges and opportunities in the display industry
Mini LEDs and micro LEDs are expected to become improved backlighting solutions that can significantly enhance displays quality and create added value in the upcoming years.
Global server shipment forecast and industry analysis, 2020
Digitimes Research estimates that global server shipments moderately declined 1.4% in 2019 but will turn to show positive growth of 6.6% in 2020, totaling 16.01 million units.
Global AP demand forecast, 2017-2022
Worldwide shipments of smartphone application processors are expected to fall.

Digitimes Research Quarterly Data services

© 2020 DIGITIMES Inc. All rights reserved.
Please do not republish, publicly broadcast or publicly transmit content from this website without written permission from DIGITIMES Inc. Please contact us if you have any questions.

Members only